Company / FCF Margin
ORAMED PHARMACEUTICALS INC. FCF Margin History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest FCF Margin
-421.5%
FY2025
5-year range
-1051.2% / -421.5%
FY2021-FY2025
Trend
+46.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
FCF Margin has fluctuated over the past 10 years, ranging from -1051.2% in FY2023 to 724.8% in FY2018.
Based on SEC 10-K filings.
-421.5% in FY2025 with a 5-year CAGR of +57.8%.
Improved from -1051.2% to -421.5% over the past 2 years.
FCF Margin over time
Growth rates
- 3-Year Change
- +376.0pp
- 5-Year Change
- +57.8pp
- 10-Year Change
- -
Key checks
Key Insights
- In FY2025, fcf margin increased 46.5% year-over-year.
- Peak fcf margin was recorded in FY2018.
- Lowest fcf margin in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score 0.91 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | FCF MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -421.5% | +46.5% |
| FY2024 | -787.2% | +25.1% |
| FY2023 | -1051.2% | -31.8% |
| FY2022 | -797.5% | -72.6% |
| FY2021 | -462.1% | +3.6% |
| FY2020 | -479.3% | -101.6% |
| FY2019 | -237.7% | -132.8% |
| FY2018 | 724.8% | +193.9% |
| FY2017 | -771.8% | -21.2% |
| FY2016 | -636.8% | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026